Department of Endocrinology, Metabolism and Nephrology Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan.
Department of Haematology and Respiratory Medicine Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan.
Rom J Intern Med. 2023 Sep 5;61(4):216-221. doi: 10.2478/rjim-2023-0022. Print 2023 Dec 1.
Clopidogrel is a widely prescribed prodrug with antithrombotic activity that functions by irreversibly inhibiting the P2Y12 receptors on platelets; nevertheless, drug-induced eosinophilia from this drug is rarely reported. An 81-year-old man was diagnosed with cerebral infarction 2 months earlier and was admitted to our hospital with rash, fever, wheezing, and stomach discomfort after being initiated with clopidogrel treatment. Based on his medical history, chest CT, and gastroscopy, we diagnosed him with clopidogrel-induced hypereosinophilic syndrome. After discontinuation of clopidogrel, the eosinophilia and symptoms improved. In cases of drug-induced eosinophilia, it is important to obtain a detailed medical history.
氯吡格雷是一种广泛应用于抗血栓的前体药物,通过不可逆地抑制血小板上的 P2Y12 受体发挥作用;然而,该药引起的药物性嗜酸性粒细胞增多症很少见。一位 81 岁的男性,2 个月前被诊断为脑梗死,在开始氯吡格雷治疗后出现皮疹、发热、喘息和胃部不适而被收入我院。根据他的病史、胸部 CT 和胃镜检查,我们诊断为氯吡格雷引起的嗜酸性粒细胞增多症。停用氯吡格雷后,嗜酸性粒细胞增多和症状均得到改善。对于药物性嗜酸性粒细胞增多症,获取详细的病史很重要。